kr309.60
1.24% day before yesterday
Copenhagen, Dec 05, 05:00 pm CET
ISIN
DK0062498333
Symbol
NOVO B

Novo Nordisk Stock price

kr309.60
+8.55 2.84% 1M
-167.10 35.05% 6M
-314.60 50.40% YTD
-461.40 59.84% 1Y
-140.70 31.25% 3Y
+100.10 47.78% 5Y
+111.65 56.40% 10Y
+275.25 801.31% 20Y
Copenhagen, Closing price Fri, Dec 05 2025
+3.80 1.24%
ISIN
DK0062498333
Symbol
NOVO B
Industry

New AI Insights on Novo Nordisk Insights AI Insights on Novo Nordisk

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
kr1.4t
Enterprise Value
kr1.4t
Net debt
kr68.6b
Cash
kr32.6b
Shares outstanding
4.4b
Valuation (TTM | estimate)
P/E
13.3 | 13.0
P/S
4.3 | 4.3
EV/Sales
4.5 | 4.5
EV/FCF
23.4
P/B
8.0
Dividends
DPS
kr11.40
Yield 1Y | 5Y
3.7% | 1.6%
Growth 1Y | 5Y
21.3% | 22.3%
Payout 1Y | 3Y
50.4% | 50.5%
Increased
18 Years
Financials (TTM | estimate)
Revenue
kr315.6b | kr317.2b
EBITDA
kr154.3b | kr155.8b
EBIT
kr132.7b | kr138.5b
Net Income
kr103.8b | kr105.8b
Free Cash Flow
kr61.0b
Growth (TTM | estimate)
Revenue
16.6% | 9.2%
EBITDA
14.1% | 9.6%
EBIT
12.1% | -0.3%
Net Income
9.6% | 4.7%
Free Cash Flow
-9.1%
Margin (TTM | estimate)
Gross
82.1%
EBITDA
48.9% | 49.1%
EBIT
42.0%
Net
32.9% | 33.4%
Free Cash Flow
19.3%
Financial Health
Equity Ratio
30.8%
Return on Equity
70.4%
ROCE
47.7%
ROIC
40.6%
Debt/Equity
0.6
More
EPS
kr23.3
FCF per Share
kr13.7
Short interest
-
Employees
77k
Rev per Employee
kr3.8m
Show more

Is Novo Nordisk a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Novo Nordisk Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Novo Nordisk forecast:

18x Buy
56%
11x Hold
34%
3x Sell
9%

Analyst Opinions

32 Analysts have issued a Novo Nordisk forecast:

Buy
56%
Hold
34%
Sell
9%

Financial data from Novo Nordisk

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
315,603 315,603
17% 17%
100%
- Direct Costs 56,664 56,664
37% 37%
18%
258,939 258,939
13% 13%
82%
- Selling and Administrative Expenses 73,122 73,122
11% 11%
23%
- Research and Development Expense 51,193 51,193
31% 31%
16%
154,277 154,277
14% 14%
49%
- Depreciation and Amortization 21,618 21,618
28% 28%
7%
EBIT (Operating Income) EBIT 132,659 132,659
12% 12%
42%
Net Profit 103,773 103,773
10% 10%
33%

In millions DKK.

Don't miss a Thing! We will send you all news about Novo Nordisk directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novo Nordisk Stock News

AD HOC NEWS
13 days ago
Die US-Bank JPMorgan hat die Einstufung für Novo Nordisk DK0062498333 auf "Overweight" mit einem Kursziel von 500 dänischen Kronen belassen.
AD HOC NEWS
14 days ago
Die DZ Bank hat die Einstufung für Novo Nordisk DK0062498333 nach dem Fehlschlag einer Alzheimer-Studie auf "Halten" mit einem fairen Wert von 313 dänischen Kronen belassen.
AD HOC NEWS
14 days ago
Das Abnehmmittel Semaglutid des Pharmakonzerns Novo Nordisk DK0062498333 hat in einer Alzheimer-Studie nicht den erwünschten Erfolg gebracht.
More Novo Nordisk News

Company Profile

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Head office Denmark
CEO Lars Jørgensen
Employees 76,826
Founded 1931
Website www.novonordisk.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today